Consilient

Consilient Appoints Accomplished Technology Leader Ajit Tharaken as its new CEO

Retrieved on: 
Lundi, décembre 18, 2023
Fraud, Federated, Consilient, Management

WASHINGTON, Dec. 18, 2023 /PRNewswire/ -- Consilient, the leading Federated Learning/AI company dedicated to the prevention of financial crime and fraud, proudly announces the appointment of Ajit Tharaken as its new Chief Executive Officer (CEO).

Key Points: 
  • WASHINGTON, Dec. 18, 2023 /PRNewswire/ -- Consilient, the leading Federated Learning/AI company dedicated to the prevention of financial crime and fraud, proudly announces the appointment of Ajit Tharaken as its new Chief Executive Officer (CEO).
  • With an impressive track record in leadership of innovative technology functions and a wealth of experience in driving business success, Tharaken is set to lead Consilient to transform the global approach to protecting the integrity of the financial system.

K2 Integrity Participates in 29th Egmont Plenary Meetings in United Arab Emirates

Retrieved on: 
Mercredi, juillet 19, 2023
Private sector, Egmont, Senior, Central bank, Policy, Financial Crimes Enforcement Network, Intelligence, Consilient, Capacity building, Egmont Group of Financial Intelligence Units, FIU, Artificial intelligence, AI, Egmont Group, Plenary, Drug, Medical device

WASHINGTON, July 19, 2023 /PRNewswire/ -- Earlier this month, K2 Integrity's Global Co-Managing Partner and Chief Strategy Officer, Juan Zarate, and Senior Managing Director and Former Chair of the Egmont Group of Financial Intelligence Units, Mariano Federici, participated in the 29th Egmont Plenary Meetings held in Abu Dhabi, United Arab Emirates. The Plenary – which drew more than 500 participants – was hosted by the United Arab Emirates Financial Intelligence Unit (UAE-FIU), led by Ali Faisal Al B'alawi, under the patronage of His Highness Sheikh Mansour bin Sayed, Vice President, Deputy Prime Minister, Minister of the Presidential Court, and Chairman of the Central Bank of the UAE (CBUAE).

Key Points: 
  • WASHINGTON, July 19, 2023 /PRNewswire/ -- Earlier this month, K2 Integrity's Global Co-Managing Partner and Chief Strategy Officer, Juan Zarate, and Senior Managing Director and Former Chair of the Egmont Group of Financial Intelligence Units, Mariano Federici, participated in the 29th Egmont Plenary Meetings held in Abu Dhabi, United Arab Emirates.
  • Zarate noted, "K2 Integrity and our sister company Consilient were honored to present at the Egmont Plenary before a distinguished international audience to discuss the risks and promise of artificial intelligence and federated learning, more specifically.
  • K2 Integrity commends the Egmont Chair, Xolisile Kanyile, the Egmont Executive Secretary, Jerome Beaumont, the Egmont Committee, and the entire Egmont membership for fostering this much needed public-private collaboration in the fight against financial crimes.
  • K2 Integrity would also like to congratulate the UAE authorities for the outstanding organization of the 29th Plenary Meetings, and for their exquisite hospitality.

Consilient Survey Finds Money Laundering is a Misunderstood and Underestimated Problem Among Consumers

Retrieved on: 
Mercredi, juin 7, 2023
Police, Consilient, Terrorism, Drug

What: Consilient has released a consumer survey that finds money laundering is a misunderstood and underestimated problem.

Key Points: 
  • What: Consilient has released a consumer survey that finds money laundering is a misunderstood and underestimated problem.
  • The report found that consumers really do not understand the enormous extent of money-laundering that takes place every year.
  • But 65% of consumers would consider switching banks if theirs was fined for money laundering.
  • Who: To learn more about the impact of money laundering on today's society, speak with Laurence Hamilton, Consilient's Chief Commercial Officer
    How: To download the survey visit: https://consilient.com/money-launderinga-misunderstood-andunderestimated...

Consilient Expands Team Adding Jeremy Kedziora as Director of Data Science

Retrieved on: 
Lundi, juin 5, 2023
Giant, Natural language processing, University, Doctor of Philosophy, Data science, Rochester, Northwestern Mutual, Milwaukee School of Engineering, Game theory, Government, Consilient, CIA, Machine learning, Risk, Artificial intelligence, Federated learning, Management, Medical device, Engineering

WASHINGTON, June 5, 2023 /PRNewswire/ -- Consilient, a fintech innovator aiming to transform how the industry prevents financial crime, has announced that Jeremy Kedziora as joined the team as the Director of Data Science where he is responsible for advancing the company's approach in the use of Federated Learning. Kedziora brings 17 years of experience as a researcher and scientist focused on developing new methods in machine learning, Bayesian inference and game theory.

Key Points: 
  • WASHINGTON, June 5, 2023 /PRNewswire/ -- Consilient , a fintech innovator aiming to transform how the industry prevents financial crime, has announced that Jeremy Kedziora as joined the team as the Director of Data Science where he is responsible for advancing the company's approach in the use of Federated Learning.
  • Kedziora brings 17 years of experience as a researcher and scientist focused on developing new methods in machine learning, Bayesian inference and game theory.
  • Previously Kedziora was a director of data science and analytics at Northwestern Mutual, where he managed the development of cybersecurity machine learning.
  • Kedziora served nine years at the U.S. Central Intelligence Agency (CIA) as a chief methodologist where he led applied R&D efforts in data science and modeling.

Consilient Inc. and Harex InfoTech Partner to Fight Financial Crime in South Korea

Retrieved on: 
Lundi, mai 8, 2023
Learning, Semiconductor, Partnership, Small modular reactor, Information, Terrorism, Privacy, Organization, Consilient, Korean Ministry of Culture, AML, MOU, Artificial intelligence, SMR, Quantum, SME, Cryptocurrency, AI

WASHINGTON, May 8, 2023 /PRNewswire/ -- Consilient, a fintech innovator aiming to transform financial crime compliance, announced it has partnered with Harex InfoTech, Inc. to transform the fight against financial crime in South Korea. The current technologies and methods for protecting the financial system are outdated, inefficient and largely ineffective. Through the use of federated learning (FL), a revolutionary form of artificial intelligence (AI), Consilient and Harex InfoTech will transform business processes and enable dynamic risk management to prevent financial crime in the South Korean market.

Key Points: 
  • WASHINGTON, May 8, 2023 /PRNewswire/ -- Consilient , a fintech innovator aiming to transform financial crime compliance, announced it has partnered with Harex InfoTech, Inc. to transform the fight against financial crime in South Korea.
  • Through the use of federated learning (FL), a revolutionary form of artificial intelligence (AI), Consilient and Harex InfoTech will transform business processes and enable dynamic risk management to prevent financial crime in the South Korean market.
  • The Consilient and Harex InfoTech partnership forms a US-Korean AI technology alliance that will enhance the effectiveness and efficiency of Korean financial institutions in combatting financial crime.
  • "Consilient was founded to change fundamentally how financial institutions and regulators worldwide prevent financial crime.

Pharmanovia to Market GHRYVELIN™ (Macimorelin) in the European Economic Area (EEA) and UK as Diagnostic Test for Growth Hormone Deficiency (GHD)

Retrieved on: 
Jeudi, mars 16, 2023
TSX, EEA, Medicine, Novo Nordisk, Endocrinology, Patient, Diagnosis, Consilient, Knowledge, Pharmaceutical industry

Dr. Klaus Paulini, Chief Executive Officer of Aeterna commented, “Pharmanovia has established global expertise in marketing diagnostic testing solutions in addition to an established footprint in endocrinology across Europe.

Key Points: 
  • Dr. Klaus Paulini, Chief Executive Officer of Aeterna commented, “Pharmanovia has established global expertise in marketing diagnostic testing solutions in addition to an established footprint in endocrinology across Europe.
  • They are positioned as the natural choice as our commercialization partner moving forward.
  • We believe that the decision by Pharmanovia to invest in GHRYVELIN™ demonstrates the future potential of GHRYVELIN™ and is an endorsement of the efforts made to date by both Aeterna Zentaris and our former licensee, Consilient Health’s, to obtain approval for and launch GHRYVELIN™ in Europe.
  • We are excited to now have Pharmanovia as a partner as we continue our efforts to benefit patients.”
    “Endocrinology is the largest of our four core therapy areas and the in-licensing of this important novel medicine, the second in-licensing deal of a novel medicine in almost as many weeks, speaks to our ability to in-license novel, complementary products in the therapeutic settings we support,” commented Pharmanovia CEO, Dr. James Burt.

Consilient Brings to Market its Next-Generation Federated Learning Solution for Financial Crime Detection

Retrieved on: 
Mardi, février 28, 2023
Giant, Overalls, Terrorism, Noise, Organization, Crime, Partnership, Privacy, Risk, Travel, Algorithm, Environment, Machine learning, Consilient, Cryptocurrency

WASHINGTON, Feb. 28, 2023 /PRNewswire/ -- Consilient, a fintech innovator transforming the way the world addresses financial crime, today announced the next generation of the Consilient Federated Learning (FL) solution. Consilient is the first-ever FL solution for financial crime detection and prevention. The Consilient Platform and its FL models enable banks and other financial institutions to detect high-risk entities and behaviors by sharing insights across different data environments and organizations. With Consilient, algorithms travel and insights are shared, but data never leaves its environment.

Key Points: 
  • WASHINGTON, Feb. 28, 2023 /PRNewswire/ -- Consilient , a fintech innovator transforming the way the world addresses financial crime, today announced the next generation of the Consilient Federated Learning (FL) solution.
  • Consilient is the first-ever FL solution for financial crime detection and prevention.
  • Preventing financial crime and protecting the integrity of the financial system is a global imperative.
  • "Consilient is the first company to introduce FL for the detection of financial crime and it is our mission for global organizations to use FL to transform how the world prevents financial crime."

Consilient Brings to Market its Next-Generation Federated Learning Solution for Financial Crime Detection

Retrieved on: 
Mardi, février 28, 2023
Giant, Overalls, Terrorism, Noise, Organization, Crime, Partnership, Privacy, Risk, Travel, Algorithm, Environment, Machine learning, Consilient, Cryptocurrency

WASHINGTON, Feb. 28, 2023 /PRNewswire/ -- Consilient, a fintech innovator transforming the way the world addresses financial crime, today announced the next generation of the Consilient Federated Learning (FL) solution. Consilient is the first-ever FL solution for financial crime detection and prevention. The Consilient Platform and its FL models enable banks and other financial institutions to detect high-risk entities and behaviors by sharing insights across different data environments and organizations. With Consilient, algorithms travel and insights are shared, but data never leaves its environment.

Key Points: 
  • WASHINGTON, Feb. 28, 2023 /PRNewswire/ -- Consilient , a fintech innovator transforming the way the world addresses financial crime, today announced the next generation of the Consilient Federated Learning (FL) solution.
  • Consilient is the first-ever FL solution for financial crime detection and prevention.
  • Preventing financial crime and protecting the integrity of the financial system is a global imperative.
  • "Consilient is the first company to introduce FL for the detection of financial crime and it is our mission for global organizations to use FL to transform how the world prevents financial crime."

Consilient Announces $3 Million Seed Funding Round for the Development of Next-Generation Financial Crime Compliance Technology

Retrieved on: 
Mardi, mai 24, 2022
Giant, Fraud, Terrorism, Multimedia, View, Solution, Crime, Privacy, BMO Harris Bank, Industry, Partnership, Schott, Program, Technology, Organization, Consilient, Machine learning, Neobank, CEO, Cryptocurrency

WASHINGTON, May 24, 2022 /PRNewswire/ -- Consilient, a fintech innovator aiming to transform financial crime compliance, today announced it has secured a private $3 million seed funding round that will help the company's vision to become the leader in the development of next-generation machine learning technology to detect and prevent illicit activity within financial ecosystems. Consilient was founded through a partnership between K2 Integrity and Giant Oak.

Key Points: 
  • Consilient's federated machine learning technology enables organizations to discover and manage financial crime risks dynamically and effectively, while preserving privacy.
  • But recent innovations in technology can empower those individuals and teams engaged in combatting financial crime," said Gary Shiffman, CEO and co-founder of Consilient.
  • Consilient is poised to reshape the way the financial system prevents financial crime," said Juan Zarate, chairman and co-founder of Consilient.
  • Consilient has two technology patents pending for an adaptive transaction processing system and the orchestration techniques for adaptive transaction processing.

Aeterna Zentaris Secures New European Patent Related to Use of Macimorelin for the Diagnosis of Growth Hormone Deficiency in Adults

Retrieved on: 
Mardi, avril 19, 2022
ALS, Patent, Toronto Stock Exchange, Novo Nordisk, News, Marketing, COVID-19, Adult, European Commission, Parkinson's disease, Risk, EPC, NASDAQ, Legislation, Annual report, Diagnosis, Food, EC, EPO, GLOBE, Growth hormone, Chlamydia trachomatis, Amyotrophic lateral sclerosis, Royal commission, Neuromyelitis optica spectrum disorder, Pituitary gland, Company, Macimorelin, Food and Drug Administration, United Kingdom, GHD, Forward-looking statement, Hypoparathyroidism, U.S. FDA, European Patent Office, Consilient, TSX, Union, FDA, NMOSD, Severe acute respiratory syndrome coronavirus 2, PD, Generic drug, Pharmaceutical industry, EU

TORONTO, ONTARIO, April 19, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced that European Patent Office (EPO) has issued a patent providing intellectual property protection of macimorelin in 27 countries within the European Union as well as additional European non-EU countries, such as the UK and Turkey, for macimorelin (Ghryvelin®; Macrilen™) for use to diagnose growth hormone deficiency (GHD) in adults.

Key Points: 
  • Stimulated growth hormone levels are measured in blood samples after oral administration of macimorelin for the assessment of GHD.
  • Macimorelin is the only U.S. Food and Drug Administration and European Commission approved oral diagnostic for adult growth hormone deficiency.
  • The new European patent covers the use of macimorelin to detect GHD in adults, with a base patent term extending until 2038.
  • Macimorelin, is the only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD).